LANZOLLA, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 613
EU - Europa 463
AS - Asia 107
AF - Africa 34
OC - Oceania 1
Totale 1.218
Nazione #
US - Stati Uniti d'America 611
SE - Svezia 179
IT - Italia 103
BG - Bulgaria 46
DE - Germania 38
CN - Cina 33
SG - Singapore 31
FR - Francia 29
GB - Regno Unito 29
AT - Austria 27
CI - Costa d'Avorio 19
VN - Vietnam 16
SN - Senegal 13
IN - India 12
TR - Turchia 6
UA - Ucraina 4
HK - Hong Kong 3
SA - Arabia Saudita 3
BE - Belgio 2
IR - Iran 2
NG - Nigeria 2
AU - Australia 1
CA - Canada 1
ES - Italia 1
HR - Croazia 1
JP - Giappone 1
NL - Olanda 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
Totale 1.218
Città #
Chandler 107
Fairfield 85
Sofia 46
Woodbridge 42
New York 40
Seattle 40
Ashburn 37
Wilmington 35
Florence 27
Houston 26
Vienna 26
Bremen 24
London 23
Marseille 23
Lawrence 20
Princeton 20
Abidjan 19
Beijing 17
Cambridge 16
Medford 15
Dakar 13
Ann Arbor 12
Pisa 10
San Diego 9
Vicopisano 9
Dong Ket 7
Frankfurt am Main 7
Rome 6
Serra 5
Norwalk 4
Ossé 4
Singapore 4
Des Moines 3
Jeddah 3
Kent 3
Kocaeli 3
Livorno 3
Manchester 3
Milan 3
Pune 3
Viareggio 3
Ankara 2
Brussels 2
Chicago 2
Da Nang 2
Dallas 2
Guangzhou 2
Hong Kong 2
Lagos 2
New Delhi 2
Queens 2
Vertemate con Minoprio 2
Aosta 1
Baotou 1
Centerville 1
Central 1
Changsha 1
Chengdu 1
Hebei 1
Iasi 1
Istanbul 1
Mascali 1
Massarosa 1
Munich 1
Nanchang 1
Nanjing 1
Ningbo 1
Ogden 1
Ottawa 1
Panama City 1
Parma 1
San Jose 1
Sydney 1
Twickenham 1
Valencia 1
Villasanta 1
Warsaw 1
Zagreb 1
Totale 853
Nome #
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 110
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 107
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 81
Immune Checkpoint Blockade Anti-PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome 77
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 71
Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis 71
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 70
Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules 70
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study 68
Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy 65
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases 57
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy 57
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 53
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study 43
Oxidative Stress in Graves Disease and Graves Orbitopathy 31
Antioxidant Therapy in Graves’ Orbitopathy 30
Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols 30
Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease 29
Graves’ disease and Graves’ orbitopathy following COVID-19 27
Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study 26
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy 25
Statins: A New Hope on the Horizon of Graves Orbitopathy? 20
Sirolimus as a second-line treatment for Graves' orbitopathy 17
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 16
Totale 1.251
Categoria #
all - tutte 5.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 8 5
2019/2020136 4 8 7 7 8 12 12 17 20 13 24 4
2020/2021180 7 4 3 62 6 0 17 9 19 13 22 18
2021/2022284 0 2 1 25 60 38 7 8 40 47 12 44
2022/2023470 48 77 49 36 36 48 2 30 92 5 43 4
2023/2024156 4 18 17 14 18 45 17 7 2 4 10 0
Totale 1.251